These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37626391)

  • 41. Calpain inhibition attenuates bleomycin-induced pulmonary fibrosis via switching the development of epithelial-mesenchymal transition.
    Liu Y; Liu B; Zhang GQ; Zou JF; Zou ML; Cheng ZS
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Jul; 391(7):695-704. PubMed ID: 29666896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
    Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
    Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppression of TGF-β1 production and TGF-β1-induced fibroblast differentiation.
    Nie Y; Zhang D; Qian F; Wu Y
    Int Immunopharmacol; 2019 Sep; 74():105696. PubMed ID: 31229901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p90RSK Inhibition Ameliorates TGF-β1 Signaling and Pulmonary Fibrosis by Inhibiting Smad3 Transcriptional Activity.
    Kim S; Han JH; Kim S; Lee H; Kim JR; Lim JH; Woo CH
    Cell Physiol Biochem; 2020 Feb; 54(2):195-210. PubMed ID: 32083406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emodin alleviates bleomycin-induced pulmonary fibrosis in rats.
    Guan R; Zhao X; Wang X; Song N; Guo Y; Yan X; Jiang L; Cheng W; Shen L
    Toxicol Lett; 2016 Nov; 262():161-172. PubMed ID: 27717887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation.
    Kim S; Lim JH; Woo CH
    Am J Pathol; 2013 Dec; 183(6):1758-1768. PubMed ID: 24095924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maresin 1 Inhibits Epithelial-to-Mesenchymal Transition in Vitro and Attenuates Bleomycin Induced Lung Fibrosis in Vivo.
    Wang Y; Li R; Chen L; Tan W; Sun Z; Xia H; Li B; Yu Y; Gong J; Tang M; Ji Y; Yuan S; Shanglong Yao ; Shang Y
    Shock; 2015 Nov; 44(5):496-502. PubMed ID: 26196843
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Suppressive Regulation by MFG-E8 of Latent Transforming Growth Factor β-Induced Fibrosis via Binding to αv Integrin: Significance in the Pathogenesis of Fibrosis in Systemic Sclerosis.
    Fujiwara C; Uehara A; Sekiguchi A; Uchiyama A; Yamazaki S; Ogino S; Yokoyama Y; Torii R; Hosoi M; Suto C; Tsunekawa K; Murakami M; Ishikawa O; Motegi SI
    Arthritis Rheumatol; 2019 Feb; 71(2):302-314. PubMed ID: 30175895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
    Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
    J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis.
    Suzuka T; Kotani T; Saito T; Matsuda S; Sato T; Takeuchi T
    Arthritis Res Ther; 2022 Oct; 24(1):228. PubMed ID: 36207753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin.
    Ohashi T; Yamamoto T
    Exp Dermatol; 2015 Sep; 24(9):698-702. PubMed ID: 25959255
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis.
    Hasegawa M; Matsushita Y; Horikawa M; Higashi K; Tomigahara Y; Kaneko H; Shirasaki F; Fujimoto M; Takehara K; Sato S
    Arthritis Rheum; 2009 Nov; 60(11):3465-75. PubMed ID: 19877032
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dissection of the mechanism of traditional Chinese medical prescription-Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis.
    Wu T; Chu H; Tu W; Song M; Chen D; Yuan J; Yu L; Ma Y; Liu Q; Jin L; Zhou X; Zou H; Wu W; Wang J
    BMC Complement Altern Med; 2014 Jul; 14():224. PubMed ID: 24998426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 5-HT
    Chaturvedi S; Misra DP; Prasad N; Rastogi K; Singh H; Rai MK; Agarwal V
    Int J Rheum Dis; 2018 Dec; 21(12):2128-2138. PubMed ID: 30207074
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lysine-specific demethylase-1 regulates fibroblast activation in pulmonary fibrosis via TGF-β1/Smad3 pathway.
    Pan X; Li J; Tu X; Wu C; Liu H; Luo Y; Dong X; Li X; Pan LL; Sun J
    Pharmacol Res; 2020 Feb; 152():104592. PubMed ID: 31830521
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
    Pamuk ON; Can G; Ayvaz S; Karaca T; Pamuk GE; Demirtas S; Tsokos GC
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
    Pan R; Zhang Y; Zang B; Tan L; Jin M
    J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-fibrotic effect of iguratimod on pulmonary fibrosis by inhibiting the fibroblast-to-myofibroblast transition.
    Lin H; Wu C; Zhu F; Zhang G; Xie Y; Cui Y; Dong G; Zhang X
    Adv Med Sci; 2020 Sep; 65(2):338-347. PubMed ID: 32590154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exercise training ameliorates bleomycin-induced epithelial mesenchymal transition and lung fibrosis through restoration of H
    Du SF; Wang XL; Ye CL; He ZJ; Li DX; Du BR; Liu YJ; Zhu XY
    Acta Physiol (Oxf); 2019 Feb; 225(2):e13177. PubMed ID: 30136377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bone morphogenetic protein-7 inhibits endothelial-to-mesenchymal transition in primary human umbilical vein endothelial cells and mouse model of systemic sclerosis via Akt/mTOR/p70S6K pathway.
    Shen C; Jiang Y; Li Q; Liu C; Hu F; Li M
    J Dermatol Sci; 2021 Aug; 103(2):82-92. PubMed ID: 34266726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.